Fig. 5

Anti-oxidative and anti-inflammatory effects of AERCAP on TNBS-induced colitis in rats. a. MDA content, ANOVA, F_(5,38) = 5.88, p < 0.001; b MPO activity, ANOVA, F_(5,38) = 0.290, p < 0.05; n = 6–8, followed by LSD test; columns present the mean ± S.E.M. c TNF-α level, d IL-1β level, Kruskal-Wallis test, p < 0.01, followed by Dunn’s multiple comparison test, n = 6–8, boxes presented Q25%-Q75%. *p < 0.05, ***p < 0.001, compared with health control group; +p < 0.05, +++p < 0.001, compared with the TNBS control group